The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study

BACKGROUND: Omalizumab is a non-steroidal medication indicated for the treatment of poorly controlled moderate-to-severe allergic asthmatics. This observational study examines the “real world” effectiveness of omalizumab in this population. METHODS: This is a one year open-label observational study...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhutani, Mohit, Yang, William H., Hébert, Jacques, de Takacsy, Frederica, Stril, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578673/
https://www.ncbi.nlm.nih.gov/pubmed/28859150
http://dx.doi.org/10.1371/journal.pone.0183869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578673/
https://www.ncbi.nlm.nih.gov/pubmed/28859150
http://dx.doi.org/10.1371/journal.pone.0183869

Ejemplares similares